We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Male Boost Plus (Glimlife Australia Pty Ltd)
Product Name
Male Boost Plus
Sponsor
Date of review outcome
Date of publication
Sep-2024
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes, based on the sponsor's certification. However, follow the recommended actions below.
What action should consumers take?
Seek advice from a medical practitioner if you are or have been using this medicine for kidney problems, prostate and testicular symptoms, sexual dysfunction, premature ejaculation, supporting fertility and/or erectile function.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to the conditions described above, as well as claims about improving general wellbeing, supporting sexual function, libido, reproductive system and prostate health, enhancing sexual performance, supporting healthy testosterone levels, sperm motility, liver health, as well as claims about this medicine being suitable for people with frequent urination, mild anxiety and poor sleep quality.
Consider whether this medicine is right for you based on it potentially not working as expected in relation to the conditions described above, as well as claims about improving general wellbeing, supporting sexual function, libido, reproductive system and prostate health, enhancing sexual performance, supporting healthy testosterone levels, sperm motility, liver health, as well as claims about this medicine being suitable for people with frequent urination, mild anxiety and poor sleep quality.
Review scope
Targeted
Information reviewed
ARTG Record, Website
Issues related to safety
The website for this medicine contained claims specified in 'What action should consumers take?' above. Some of these claims are not permitted for listed medicines without prior evaluation or approval from the TGA. References to non-permitted claims have the potential to lead consumers to delay access to timely advice or treatment from a suitably qualified health professional when required, which may result in adverse outcomes.
In addition, the website contained references to substances not permitted for use in listed medicines. Such advertising has the potential to promote or discourage the use of these substances for health conditions without the oversight of suitably qualified health professionals.
While the above advertising is unacceptable, the claims have been removed from the website and current data indicates that the use of this medicine is unlikely to pose an immediate risk to consumer health and safety.
In addition, the website contained references to substances not permitted for use in listed medicines. Such advertising has the potential to promote or discourage the use of these substances for health conditions without the oversight of suitably qualified health professionals.
While the above advertising is unacceptable, the claims have been removed from the website and current data indicates that the use of this medicine is unlikely to pose an immediate risk to consumer health and safety.
Issues related to efficacy
The website for this medicine contained claims specified in 'What action should consumers take?' above. However, these claims were not covered by the sponsor's certification that they held evidence to substantiate them.
In addition, the sponsor certified they held traditional use evidence for claims about improving general wellbeing, supporting sexual function, libido, reproductive system and prostate health. However, they advertised these claims on the website in a way that incorrectly implied they were supported by scientific evidence.
In addition, the sponsor certified they held traditional use evidence for claims about improving general wellbeing, supporting sexual function, libido, reproductive system and prostate health. However, they advertised these claims on the website in a way that incorrectly implied they were supported by scientific evidence.
Actions taken during the review
The sponsor updated the website to remove some of the claims specified in 'What action should consumers take?'. The TGA issued an educational letter to the sponsor regarding these issues, and required the sponsor to correct the remaining issues with this medicine. The sponsor updated the website to correct the issues.